Reports for TEVA-SUCRALFATE
Brand name
TEVA-SUCRALFATE
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02045702 |
Ingredients
SUCRALFATE |
Ingredient Strength
1 G |
ATC Code
A02BXA02BX |
ATC Descriptor
DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
TEVA-SUCRALFATE | 500 | Resolved | 2021-04-01 | 2021-04-08 | 136759 |
TEVA-SUCRALFATE | 500 | Resolved | 2021-04-29 | 2021-05-13 | 138300 |
TEVA-SUCRALFATE | 500 | Resolved | 2021-06-17 | 2021-07-22 | 141113 |
TEVA-SUCRALFATE | 500 | Resolved | 2021-09-30 | 2021-11-05 | 146469 |
TEVA-SUCRALFATE | 500 | Resolved | 2021-12-17 | 2022-01-20 | 151468 |
TEVA-SUCRALFATE | 500 | Resolved | 2023-02-16 | 2023-06-09 | 184934 |
TEVA-SUCRALFATE | 500 | Resolved | 2023-06-16 | 2023-07-21 | 195039 |
TEVA-SUCRALFATE | 500 | Resolved | 2023-07-27 | 2023-08-04 | 200210 |
TEVA-SUCRALFATE | 500 | Resolved | 2023-08-17 | 2023-10-04 | 202228 |
TEVA-SUCRALFATE | 500 | Actual shortage | 2023-12-14 | 2024-02-22 | 213368 |
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0